Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp MDXHF


Primary Symbol: V.MDX

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by hopefullon Sep 05, 2024 3:29pm
189 Views
Post# 36210448

Worth the read and make your own conclusions

Worth the read and make your own conclusionsIn the article below put up by Toronto in 2023 indicated that Medx had a landmark deal with Pharma choice to pilot 20 locations and upon acceptance would grow significantly. The article also goes on to say that not all locations would have the Siascope but a significant amount would.
Seeing how it's been a year iand a bit and based on the latest financials one has to conclude a number of things that $1,300 and change in syoscopy scans does not equate to a deal that Pharma choice had made and begs the question what happened to the deal. It also begs the question that at some point Medx had a similar deal with the UK Health partners and again nothing has materialized from that.

So the question we all should be asking is a does leadership value its integrity because they've not been honest with the shareholders and they've not been transparent. Are the numbers of pilots actual and real so the real question behind all of this is can this company be trusted with your money. Based on Tormonts  report one was led to believe that there was an agreement with Pharma choice however unable to find any information on any stores advertising any scans.

So love to hear anyone's input on this.
https://www.medxhealth.com/tormont50-medx-health-report/
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse